Connect with us

Company News

Grant Of Second Patent To Dr. Ashish Patil MD Of Tejnaksh Healthcare Ltd

Dr. Ashish Rawandale Patil has been granted his second patent for the 5 Part Access Needle (5-PANG needle). Dr Ashish Rawandale Patil is the only urologist to have received two patents.

PCNL is a keyhole surgery done to endoscopically remove a stone from the kidney. Conventionally the technique has been described in the Western countries and instruments manufactured by the Western countries are to be used to perform the surgery. Existing instruments have a lot of disadvantages, they are expensive and have to be procured from overseas companies. The 5-PANGPCNL system is an indigenously developed instrument which removes all the drawbacks of the conventionally available foreign instruments, makes PCNL easy to learn, safe to perform and affordable to the patient. Grant of the patent to Dr Ashish would now open a new chapter in PCNL instrumentation giving him and Tejnaksh Healthcare the Liberty of being the sole owner of the intellectual rights to the instrument and the technique. Processes are underway to set up or manufacturing and distribution chain for the instrument.

Advantages of the 5-PANG PCNL:

The 5-PANG PCNL essentially removes/ eliminates all the complications of the conventional PCNL and makes the operation easy to learn for the beginner surgeons. It decreases the bleeding during the surgery. It can be used with ultrasound as well as xray machines and can be used for many cases because it is re-sterilizable. It decreases the radiation time and hence is safe for the patient, doctors and paramedical staff. It saves on the disposables. Hence it makes the whole procedure fast, effective and safe. The technique has also appeared in a recently published textbook of urology (Surgical techniques in Pediatric and Adolescent Urology – Chapter 89).

Patent grant of the 5-PANG PCNL is thus a major landmark in the history of endoscopic removal of the stone/ PCNL. This invention has proved that an instrument made in India is not only more effective then the foreign equipment but at the same time reduces the dependency on overseas companies for the technique and instruments.

Shares of Tejnaksh Healthcare Ltd was last trading in BSE at Rs.57 as compared to the previous close of Rs. 59.8. The total number of shares traded during the day was 100 in over 1 trades.

The stock hit an intraday high of Rs. 57 and intraday low of 57. The net turnover during the day was Rs. 5700.-Equity Bulls

Copyright © 2024 Medical Buyer

error: Content is protected !!